Lu Peng has filed 20 insider transactions across 1 company since April 2026.
Most recent transaction: a tax payment of 117 shares of Pharvaris N.V. ($PHVS) on May 12, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | F | Common Stock | 117 | $29.95 | 65,857.0000 | 65,210,590 | 0.18% | 0.00% |
| May 11, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | F | Common Stock | 109 | $30.09 | 65,974.0000 | 65,210,590 | 0.16% | 0.00% |
| May 1, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 143 | $0.00 | 205,308.0000 | 65,210,590 | 0.07% | 0.00% |
| May 1, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Common Stock | 14166 | $2.59 | 80,249.0000 | 65,210,590 | 21.44% | 0.02% |
| May 1, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 14023 | $0.00 | 205,451.0000 | 65,210,590 | 6.39% | 0.02% |
| May 1, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 143 | $31.00 | 66,083.0000 | 65,210,590 | 0.22% | 0.00% |
| May 1, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 14023 | $30.16 | 66,226.0000 | 65,210,590 | 17.47% | 0.02% |
| April 30, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 15000 | $30.24 | 66,083.0000 | 65,210,590 | 18.50% | 0.02% |
| April 29, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Common Stock | 3733 | $2.59 | 69,816.0000 | 65,210,590 | 5.65% | 0.01% |
| April 29, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 3733 | $30.06 | 62,350.0000 | 65,210,590 | 5.65% | 0.01% |
| April 30, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Common Stock | 15000 | $2.59 | 81,083.0000 | 65,210,590 | 22.70% | 0.02% |
| April 29, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 3733 | $0.00 | 234,474.0000 | 65,210,590 | 1.57% | 0.01% |
| April 30, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 219,474.0000 | 65,210,590 | 6.40% | 0.02% |
| April 23, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 100 | $30.03 | 66,083.0000 | 65,210,590 | 0.15% | 0.00% |
| April 23, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 106,207.0000 | 65,210,590 | 0.09% | 0.00% |
| April 22, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 7001 | $0.00 | 106,307.0000 | 65,210,590 | 6.18% | 0.01% |
| April 22, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Common Stock | 7001 | $2.59 | 73,084.0000 | 65,210,590 | 10.59% | 0.01% |
| April 23, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | M | Common Stock | 100 | $2.59 | 66,183.0000 | 65,210,590 | 0.15% | 0.00% |
| April 22, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | S | Common Stock | 7001 | $30.05 | 66,083.0000 | 65,210,590 | 9.58% | 0.01% |
| April 16, 2026 | Pharvaris N.V. | $PHVS | Lu Peng | Chief Medical Officer | F | Common Stock | 226 | $28.78 | 66,083.0000 | 65,210,590 | 0.34% | 0.00% |